Emerging Biopharma

Ready to accelerate asset success for better patient outcomes?

Every decision matters on your asset journey. Partner with IQVIA’s dedicated team to navigate commercial journeys fueled by innovation and strategic insights, therapeutic expertise, and best-in-class tailored solutions that minimize risks and maximize return on investments. 

Video Player is loading.
Current Time 0:00
Duration 1:17
Loaded: 0.00%
Stream Type LIVE
Remaining Time 1:17
 
1x
    • Chapters
    • descriptions off, selected
    • subtitles off, selected
    • en (Main), selected

    Is your asset launch strategy ready for success?

    For emerging biopharma and biotech companies, a deep understanding of patient profiles and market dynamics is vital from clinical to commercial stages.

    • IQVIA Asset Maximizer: This comprehensive solution suite, delivered by dedicated experts, helps your breakthroughs reach patients faster.
    • Early Value Demonstration: Asset success starts early. Clinical trial design must consider endpoints that demonstrate value to all stakeholders: regulators, payers, prescribers, and patients.
    • Omnichannel Engagement: Communicating that value requires an adaptable, omnichannel approach to activate and engage all stakeholders from launch and throughout the product lifecycle.

    Partnering for Success
    Work with IQVIA, the global leader in clinical development, Real World Evidence, and new treatment commercialization, to ensure your asset's success.

    ON DEMAND WEBINAR
    A Brave New World: Trends Influencing Life Sciences Investments
    Gain valuable investment insights in the life sciences landscape and key trends shaping strategies for the next decade. Join IQVIA’s Luke Greenwalt, VP and Lead, Market Access COE to learn how market shifts are creating investment opportunities for the next decade.

    Strategic commercialization for emerging biopharma success.

    Biopharmas initializing first launch

    Right-sized commercial solutions

    Our success is measured by your success. We help you maximize the impact of your investments while maintaining control of your assets, with infrastructure support, expertise, and resources. Together, we can help you scale quickly, bringing your innovation to the patients who need it.

    • Optimize go to market strategies
    • Accelerate investor valuation
    • Build an efficient and effective operating model
    Biopharmas navigating an evolving portfolio

    Scale to accelerate growth

    Get access to the resources, thought leadership and expertise to deliver the most value at launch and beyond as your portfolio grows. Stay one step ahead with the largest curated data sets, healthcare-grade AI, and therapeutic expertise to deliver short-term ROI and long-term prosperity.

    • Innovative analytics and insights
    • Optimize go to market strategies to commercialize with confidence
    • Future vision for life cycle management
    Insight Brief
    Trends Influencing Life Sciences Investments: The New Commercial Model
    This Insight Brief delves into the dynamic shifts reshaping the life sciences industry, driven by the Inflation Reduction Act, GLP-1 treatments, technology advancements, evolving care models and other market pressures.

    IQVIA BIOTECH

    Clinical development solutions built for biotech success

    Hit your clinical development milestones and maximize your patient impact.
    Insight Brief
    De-Risking Early-Stage Biotech: Turning Vision into Venture Capital
    Why early commercial thinking, stakeholder alignment, and scenario modeling are your best fundraising tools
    Contact Us